Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • A Cruise to Cure Cancer

    Because Janet, a travel agent, lost family and friends to cancer, she wanted to create a cruise…

    February 17, 2016| CRI Staff
  • Genetically Engineered CAR T Cells Prove Highly Effective Against Blood Cancers

    The era of powerful, personalized medicine draws near.

    February 17, 2016| Arthur N. Brodsky, PhD
  • FDA Regulatory Definitions

    You heard that a drug in clinical trials was Fast Tracked. Or you heard that a treatment…

    February 12, 2016| Alexandra Mulvey
  • ASCO Names Cancer Immunotherapy “Advance of the Year”

    ASCO President: “No recent cancer advance has been more transformative than immunotherapy.”

    February 5, 2016| Alexandra Mulvey
  • #WeCanICan: The Cure is International

    World Cancer Day is both a celebration of the progress we’ve made so far, and a call…

    February 4, 2016| Alexandra Mulvey
  • Cancer Immunotherapy Reverses Alzheimer’s in Mice

    A checkpoint inhibitor may offer hope for Alzheimer’s patients.

    February 3, 2016| Arthur N. Brodsky, PhD
  • FDA Approval Expands Immunotherapy Options for Advanced Melanoma

    Immunotherapy combinations continue to shine against melanoma.

    January 27, 2016| Arthur N. Brodsky, PhD
  • New Philanthropy Partnership with GuideVine

    New year, new partnerships! On January 1, 2016, GuideVine Technologies, Inc., announced the Cancer Research Institute as…

    January 27, 2016| Katherine McCluskey
  • Biden’s Cancer “Moonshot”: PBS Interview with CRI Scientist

    Vice President Joe Biden declared that we are going to take a “moonshot” at cancer, to cure…

    January 22, 2016| Arthur N. Brodsky, PhD
Previous Page
1 … 80 81 82 83 84 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal